Padma KodukulaSVP Business Development and Strategy at Precision Nanosystems
Since 2018, Padma Kodukula is Senior Vice President, Business Development and Strategy and part of the executive team at Precision NanoSystems where she is responsible for global business development activities, including strategic commercial deals, licensing, collaborations and partnerships.
Padma has worked in the diagnostic, pharmaceutical and research industries with success in closing strategic partnerships and leading the development and launch of multiple technology platforms and therapeutics. Padma currently sits on the Board of Directors for Gene Tox Lab Solutions, a speciality lab solutions company.
From 2014-2018, Padma worked within the business development team at Human Longevity Inc. where she fostered collaborative partnerships with pharma, academia and health systems to deliver on the promise of genomics and data analytics to revolutionize healthcare. From 2010 to 2014, Padma worked within the out-licensing and commercialization team at Life Technologies managing the qPCR and capillary electrophoresis platforms and enabling collaborative partnerships with molecular diagnostics and pharmaceutical companies. Prior to that Padma held various program management and alliance management roles at Prometheus Laboratories, Biosite, Pfizer and BD Biosciences.
Padma received her PhD in viral immunology from University of Illinois at Chicago and MBA from San Diego State University.